Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

A novel CRISPR therapy is poised to gain the first FDA approval for altering genes inside the body. Specific details regarding the therapy or its current stage were not provided in the context.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.